Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.

Abstract : The natural flavonoid fisetin (3,3',4',7-tetrahydroxyflavone) has shown antitumour activity but its administration is complicated by its low water solubility. Our aim was to incorporate fisetin into a nanoemulsion to improve its pharmacokinetics and therapeutic efficacy. Solubility and emulsification tests allowed to develop an optimal nanoemulsion composed of Miglyol 812N/Labrasol/Tween 80/Lipoid E80/water (10%/10%/2.5%/1.2%/76.3%). The nanoemulsion had an oil droplet diameter of 153 ± 2 nm, a negative zeta potential (-28.4 ± 0.6 mV) and a polydispersity index of 0.129. The nanoemulsion was stable at 4 °C for 30 days, but phase separation occurred at 20 °C. Pharmacokinetic studies in mice revealed that the fisetin nanoemulsion injected intravenously (13 mg/kg) showed no significant difference in systemic exposure compared to free fisetin. However, when the fisetin nanoemulsion was administered intraperitoneally, a 24-fold increase in fisetin relative bioavailability was noted, compared to free fisetin. Additionally, the antitumour activity of the fisetin nanoemulsion in Lewis lung carcinoma bearing mice occurred at lower doses (36.6 mg/kg) compared to free fisetin (223 mg/kg). In conclusion, we have developed a stable nanoemulsion of fisetin and have shown that it could improve its relative bioavailability and antitumour activity.
Type de document :
Article dans une revue
International Journal of Pharmaceutics, Elsevier, 2012, 427 (2), pp.452-9. 〈10.1016/j.ijpharm.2012.02.025〉
Liste complète des métadonnées

Littérature citée [35 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00709735
Contributeur : Guy Chabot <>
Soumis le : mardi 19 juin 2012 - 12:59:38
Dernière modification le : jeudi 11 janvier 2018 - 06:23:11
Document(s) archivé(s) le : jeudi 20 septembre 2012 - 02:26:24

Fichier

Ragelle_et_al_accepted_IJP_201...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Héloïse Ragelle, Sylvie Crauste-Manciet, Johanne Seguin, Denis Brossard, Daniel Scherman, et al.. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.. International Journal of Pharmaceutics, Elsevier, 2012, 427 (2), pp.452-9. 〈10.1016/j.ijpharm.2012.02.025〉. 〈inserm-00709735〉

Partager

Métriques

Consultations de la notice

480

Téléchargements de fichiers

2202